SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Celsius Holdings, Inc. engages in the development, marketing, sale, and distribution of functional drinks and liquid supplements. It also offers post-workout functional energy drinks and protein bars. The company was founded in April 2004 and is headquartered in Boca Raton, FL.

Celsius Holdings Inc

Celsius Holdings is experiencing heightened volatility as investors weigh strong market share gains and brand strength against concerns over margin pressure and heavy exposure to the North American market ahead of its upcoming earnings report. The community remains deeply divided, with many long-term holders pointing to robust revenue growth and Alani Nu's expansion as reasons to buy the dip, while skeptics focus on potential guidance misses and increasing competition in the energy drink space.

SoundHound AI, Inc. engages in the development, owning, and commercialization of voice, sound, and natural language artificial intelligence technologies and related activities. The company was founded by Keyvan Mohajer, Majid Seyed Emami and James M. Hom on September 2, 2005 and is headquartered in Santa Clara, CA.

SoundHound AI Inc - Ordinary Shares - Class A

SoundHound AI Inc

SoundHound AI is trending as investors respond to a strong Q2 earnings report that beat revenue expectations and featured a raise in full-year guidance, fueling community excitement over a potential massive short squeeze given the stock's high short interest. The discourse is dominated by bullish sentiment regarding the company's enterprise AI growth and the upcoming LivePerson acquisition, as retail traders anticipate significant upward momentum and potential margin calls for short sellers.

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Novavax, Inc.

Novavax Inc

Novavax is currently trending as investors focus on the upcoming earnings call, with community sentiment divided between expectations for major partnership catalysts and deep frustration over a period of management silence. While some participants track technical patterns and potential licensing opportunities for Matrix-M, others remain highly skeptical, voicing concerns about leadership performance and the status of the company's combination vaccine pipeline.

AppLovin Corp. engages in the development and operation of a mobile marketing platform. It offers AppDiscovery, MAX, Adjust, and SparkLabs. Its software-based platform caters to mobile application developers to improve the marketing and monetization of applications. The company was founded by Andrew Karam, John Krystynak, and Adam Foroughi in 2011 and is headquartered in Palo Alto, CA.

Applovin Corp - Ordinary Shares - Class A

Applovin Corp

AppLovin is experiencing extreme volatility as investors react to mixed quarterly results, where a slight revenue miss and softer guidance sparked an intense sell-off despite strong year-over-year growth and profitability. The community remains deeply divided, with many traders debating whether this is a structural shift in growth momentum or a massive overreaction by algorithms to a fundamentally strong cash-flow machine.

Western Digital Corp. engages in the development, manufacture, marketing, and sale of data storage devices and solutions. The company was founded by Alvin B. Phillips in 1970 and is headquartered in San Jose, CA.

Western Digital Corp.

Western Digital shares are facing heavy selling pressure following a sector-wide pullback triggered by concerns over China's growing semiconductor self-sufficiency and reports of state-backed manufacturing advances. While the community remains divided, many investors are framing the dip as a temporary sentiment-driven correction, pointing to persistent long-term storage demand and backlogged enterprise orders as evidence that the AI-driven cycle remains intact.

Oscar Health, Inc. is a healthcare insurance company, which serves its customers through a technology platform. It offers individual and family, small group and medicare advantage plans, and technology platform to others within the provider and payor space. The company was founded by Mario Tobias Schlosser, Kevin Nazemi, and Joshua Kushner on October 25, 2012 and is headquartered in New York, NY.

Oscar Health Inc - Ordinary Shares - Class A

Oscar Health is experiencing strong momentum as investors weigh a bullish long-term growth thesis against recent volatility and sector rotation. While the community is actively debating the stock's potential for sustained margin expansion and its ability to challenge traditional insurance giants, sentiment is currently anchored by institutional accumulation and optimism regarding management's profitability targets.

Redwire Corp. engages in the development and provision of space and defense technologies and mission-critical solutions for government, commercial, and civil customers. Its offerings include spacecraft platforms, space infrastructure, avionics, sensors and payloads, power generation systems, radio frequency systems, microgravity research and manufacturing technologies, autonomous systems, optical sensors, and digital engineering solutions. The company was founded in 2020 and is headquartered in Jacksonville, FL.

Redwire Corporation

Redwire Corp

Redwire Corp is trending as investors react to strong earnings results, with the community actively debating whether the company's record backlog and defense contract wins justify its current valuation amidst ongoing cash burn. Sentiment remains divided between bulls focused on the potential for a short squeeze and long-term space infrastructure growth, and skeptics who are concerned about the company's history of equity dilution and persistent net losses.

HubSpot, Inc. engages in cloud-based customer relationship management. Its platform includes marketing, sales, service, operations and content management systems, as well as other tools, integrations, and native payment solutions. The company was founded by Brian Patrick Halligan and Dharmesh Shah on April 4, 2005, and is headquartered in Cambridge, MA.

HubSpot Inc

HubSpot is trending after its latest earnings report triggered a sharp decline, with investors reacting to conservative forward guidance and concerns regarding the company's long-term AI-driven growth transition. Despite solid recent performance, the community is actively debating whether the current selloff represents an overreaction and an attractive buying opportunity or if the stock faces deeper challenges from increased AI-driven competition.

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly on May 10, 1876 and is headquartered in Indianapolis, IN.

Lilly(Eli) & Co

Eli Lilly is surging on the back of blockbuster earnings, with surging demand for Zepbound and Mounjaro cementing its dominance in the weight-loss and diabetes drug market. The community is actively debating the company's long-term monopoly potential, its strategic R&D secrecy, and the ongoing competitive pressure it continues to exert on rivals like Novo Nordisk.

IonQ, Inc. develops and manufactures quantum computers. The firm specializes in quantum computing and quantum information processing. The company was founded by Christopher Monroe and Jung Sang Kim in 2015 and is headquartered in College Park, MD.

IonQ Inc

IonQ is trending as investors react to the company closing its acquisition of SkyWater Technology and positioning itself for long-term growth through increased vertical integration and manufacturing control. The community remains deeply divided, with bulls pointing to the potential for accelerated production and government contract wins, while bears continue to raise concerns regarding persistent GAAP losses, high share dilution, and the company's valuation relative to its current operational scale.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

AngioDynamics to Participate in Upcoming Investor Conferences

AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the bodys vascular system, expanding cancer treatment options and improving patient quality of life, today announced that its management team is scheduled to...

AngioDynamics (ANGO) Q4 2026 Earnings Call Transcript

@media (max-width: 768px) {
 .image-container {
 width: 100% !important;
 float: none !important;
 margin: 0 0 1rem 0 !important;
 }
 }

Image source: The Mo...

AngioDynamics Q4 Earnings Beat Estimates, Gross Margin Expands

ANGO's Q4 FY26 revenues rise 8% as Med Tech surges, while its adjusted loss beats estimates and FY27 sales guidance tops consensus.

Full Transcript: AngioDynamics Q4 2026 Earnings Call

AngioDynamics (NASDAQ:ANGO) released fourth-quarter financial results and hosted an earnings call on Tuesday. Read the complete transcript below.
This content is powered by Benzinga APIs. For comprehensive financialread more...

AngioDynamics (ANGO) Reports Q4 Loss, Beats Revenue Estimates

AngioDynamics (ANGO) delivered earnings and revenue surprises of +36.36% and +7.61%, respectively, for the quarter ended May 2026. Do the numbers hold clues to what lies ahead for the stock?

AngioDynamics Reports Record Fiscal Year 2026 Fourth Quarter and Full Year Financial Results; Continued Execution Drives Med Tech Growth and Full-Year Profitability

AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the bodys vascular system, expanding cancer treatment options, and improving quality of life for patients, today announced financial results for the fourth quarter...

AngioDynamics to Report Fiscal 2026 Fourth Quarter and Full-Year Financial Results on July 14, 2026

AngioDynamics, Inc. (NASDAQ: ANGO), a medical technology company focused on restoring healthy blood flow in the body's vascular system, expanding cancer treatment options and improving patient quality of life, today announced that it will report financial results for the fourth quarter and full...

Reasons to Hold AngioDynamics Stock in Your Portfolio for Now

ANGO's NanoKnife growth, strong Med Tech momentum and solid Q3 results support holding the stock despite tariff and inflation pressures.

ANGO Gains FDA IDE Approval for NanoKnife BPH Feasibility Study

AngioDynamics' FDA IDE approval for RELIEF advances NanoKnife IRE study as a potential minimally invasive BPH treatment.

AngioDynamics Receives FDA IDE Approval for RELIEF Feasibility Study Evaluating NanoKnife IRE Platform as Minimally Invasive Treatment for Benign Prostatic Hyperplasia (BPH)

AngioDynamics, Inc. (NASDAQ: ANGO), a medical technology company focused on restoring healthy blood flow in the body's vascular system, expanding cancer treatment options and improving patient quality of life, today announced that the U.S. Food and Drug Administration (FDA) has approved the...

AngioDynamics, Inc. is a medical device company, which engages in the development, manufacturing, and sale of medical devices for vascular access, surgery, peripheral vascular disease, and oncology. The firm offers ablation systems, fluid management systems, vascular access, angiographic, drainage, thrombolytic, and venous products. It operates through the Med Tech and Med Device segments. The Med Tech segment consists of technology portfolio including Auryon, the thrombus management platform and NanoKnife. The Med Device segment focuses on core, venous, ports, and other oncology products. The company was founded by Howard S. Stern and Eamonn P. Hobbs on February 9, 1988 and is headquartered in Latham, NY.

Angiodynamic Inc

AngioDynamics Stock Rockets On Upbeat Q3, Improved Full-Year Guidance – But Retail Sentiment Plummets

Equity

Neutral Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$15.04
Prev Close	$15.19
Open	$15.27
Dividend Yield	0.00%
50-Day Moving Average	$12.97
Beta	1.07
Avg. Volume	539,867.39
PE Ratio	-16.98

52-Week High	$15.41
52-Week Low	$8.36
Market Capitalization	$627.84M
EPS (Annual)	-$0.8848
Price to Book	3.67
Revenue Per Employee	$506,604.43

Feed

News

Sentiment

Earnings

Fundamentals

Info